Improvements With Guselkumab in Psoriatic Arthritis Seen Across All MDA Domains Experts discuss importance of both physician- and patient-reported domains Dec 06, 2023 video
Deucravacitinib Improves Joint Symptoms in Psoriatic Arthritis Greater improvements over apremilast and placebo through 24 weeks Dec 05, 2023
PsA Raises Mortality Risk, but Unevenly Some psoriatic arthritis patients more vulnerable than others in Swedish study Dec 04, 2023
VTE Risk After Joint Replacement: Does Anticoagulant Choice Matter? Large claims-based study provides some answers Dec 01, 2023
New Data on Bimekizumab in Psoriatic Arthritis Roundtable of experts weigh in on "unprecedented" efficacy, and safety issues Nov 29, 2023 video
Stronger Quads May Lower Risk for Knee Replacement Surgery Higher quadricep-hamstring ratio associated with 82% lower odds in NIH cohort Nov 29, 2023
Methotrexate Tied to Greater Risks for Older Patients With CKD FDA should consider warning labels based on study results, researchers argue Nov 28, 2023
Could Correcting Metabolic Dysfunction Treat Rheumatoid Arthritis? French researchers think they've identified a truly novel approach Nov 28, 2023
Teen With Severe, Recalcitrant Dermatomyositis Seeks New Option Treatment-resistant juvenile dermatomyositis resolved by targeting elevated interferon-beta Nov 24, 2023
New Data on TYK2 Inhibitors for Psoriasis, Psoriatic Arthritis Favorable results with TAK-279 and deucravacitinib in studies at ACR Nov 22, 2023 video
Another Long-Acting Steroid Shot Impresses in Knee OA Liposomal formulation OK for repeat dosing, phase III study indicates Nov 16, 2023
Novel Gout Drug Aces Mid-Stage Tests Mechanism different from currently available therapies Nov 16, 2023
CAR T-Cell Approach to Autoimmune Disease Gains Traction Worries about vaccine responsiveness relieved; Big Pharma gets interested Nov 15, 2023
Uh-Oh, Is a Robot Coming for Your Radiographic Analysis Job? Computer matches live expert in measuring joint space and erosions Nov 15, 2023
Novel IL-17A Blocker Continues to Impress in PsA More phase II data build case for izokibep Nov 14, 2023
Some Gliflozin Side Effects Worse in Autoimmune Rheumatic Disease Something to consider when prescribing SGLT-2 inhibitors Nov 14, 2023
'Naked' Gene Therapy Promising for Osteoarthritis Phase II results pave way for bigger and better trial Nov 13, 2023
Long-Acting Steroid Gives 14 Weeks of Knee OA Relief Placebo-controlled trial gives novel product a tentative boost Nov 13, 2023
Pregnant Patients With High Autoantibody Levels Need Fetal Heart Monitoring Study should help target frequent testing to those most likely to benefit Nov 10, 2023
B-Cell Depletion Helps Maintain Kidney Function in Lupus Nephritis Secondary trial analysis boosts case for Gazyva Nov 10, 2023
X-Rays Questioned for Diagnosing Early Rheumatoid Arthritis Hardly any patients show abnormalities, so why do them? Nov 08, 2023
JAK Inhibitor Safety Study Seen Altering Practice in the VA Prescribing patterns for common RA drug shift in wake of landmark trial Nov 02, 2023
Stelara Biosimilar OK'd With Interchangeability But patent settlement may keep new product off market until 2025 Nov 01, 2023
Spinal Surgery Redux: Advancing Our Approach to Back Pain New techniques and high-quality care make all the difference for recovery Oct 30, 2023
Major Source of Lupus Morbidity More Common in Certain Racial-Ethnic Groups Good news is that it's not common overall Oct 25, 2023
Want to Reduce Knee OA Risk? Weight Work May Help History of strength training tied to reduced incidence later in life Oct 23, 2023
CDC: Arthritis Is Massive Public Health Problem One in five adults, nearly half of seniors diagnosed with joint diseases Oct 13, 2023
A Price Jump From Pennies to $20/Pill for the Same Drug Drug pricing should be subject to stricter regulation Oct 12, 2023
Acupuncture Effective for Some ED Patients With Intractable Pain Average pain score dropped from 7.96 to 3.88 after treatment, study finds Oct 11, 2023
Surprising Link Between Weight Gain and RA Activity Hint: it's not the worsening you probably expected Oct 09, 2023
Bimekizumab Data in axSpA Look Good Through 1 Year U.S. approval status for IL-17A/F inhibitor still in limbo Oct 05, 2023
Everything (Maybe) You Wanted to Know About Sarilumab for PMR Published details may raise questions about FDA's approval Oct 04, 2023
Actemra Biosimilar Approved But Biogen product doesn't get all the original's indications Oct 03, 2023
Early Oophorectomy May Accelerate Onset of Chronic Health Problems Premenopausal bilateral oophorectomy tied to higher odds of arthritis, sleep apnea, and more Sep 13, 2023
Could This Neuroleptic Ward Off RA? Retrospective data suggest a preventive effect for old-line antipsychotic drug Sep 13, 2023
Here's Another Racial-Ethnic Disparity in Back Pain Care Nonwhite patients who overuse opioids are given nonpharmacologic alternatives less often Sep 12, 2023
Rheum Patients on HCQ: Stick With It or Face Heart Consequences Population-based study links adherence with risk for cardiovascular events Sep 11, 2023